14-Year risk of all-cause mortality according to hypoglycaemic drug exposure in a general population.

PURPOSE: Guidelines for management of patients with type 2 diabetes mellitus recommend the use of hypoglycaemic drugs when lifestyle interventions remain insufficient for glycaemic control. Recent trials have provided worrying safety data on certain hypoglycaemic drugs. The aim of this study was to...

Full description

Bibliographic Details
Main Authors: Emilie Bérard, Vanina Bongard, Jean Dallongeville, Dominique Arveiler, Dominique Cottel, Aline Wagner, Jean-Bernard Ruidavets, Jean Ferrières
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3994099?pdf=render